Skip to main content

Cristina Auger Acosta

Institutions of which they are part

Research technician
Neuroradiology
Vall Hebron Institut de Recerca

Research lines

Application of MRI in multiple sclerosis and other demyelinating diseases

The objective of this research line is to evaluate the value of MRI in the diagnosis of multiple sclerosis and as a marker of progression and treatment response to disease modifying treatments.

IP: Alex Rovira Cañellas, Cristina Auger Acosta

Application of MRI in neuroncological diseases

The objective of this research line is to evaluate the value of MRI in the diagnosis and follow-up of primary tumours of central nervous system, with special interest on the impact of radiological features in predicting their genomics characteristics (radiogenomics), through multicentre studies.

IP: Cristina Auger Acosta

Application of MRI in autoimmune disorders: NMOSD and MOGAD

The objective of this research line is to evaluate the value of MRI in the diagnosis of autoimmune (NMOSD and MOGAD) diseases and as a marker of progression and treatment response.

IP: Cristina Auger Acosta, Alex Rovira Cañellas

Advanced quantitative techniques of MR Imaging in the assessment of neurological and neurooncological diseases

The objective of the line is to evaluate the added value of the information provided by quantitative MR techniques, mainly T1 and T2 relaxometry, as well as chemical exchange saturation transfer imaging (CEST) to the study of neurological and neuro-oncological diseases.

IP: Fco. Javier Aymerich Martínez, Alex Rovira Cañellas, Cristina Auger Acosta

Projects

Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a first demyelinating syndrome

IP: Alvaro Cobo Calvo
Collaborators: Cristina Auger Acosta, Marta Rodríguez Barranco, Luciana Midaglia Fernandez, Breogan Rodriguez Acevedo, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI20/00800
Duration: 01/01/2021 - 31/12/2023

Niveles en suero de neurofilamentos de cadena ligera como marcador pronóstico de evolución de la enfermedad y de respuesta al tratamiento en esclerosis múltiple

IP: Georgina Arrambide García
Collaborators: Jordi Rio Izquierdo, Cristina Auger Acosta, Marta Rodríguez Barranco, Joaquin Castillo Justribo, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI19/01590
Duration: 01/01/2020 - 31/12/2022

TRAtamiento y recuperación VISual en neuritis óptica - Estudio TRAVIS

IP: Jaume Sastre Garriga
Collaborators: Dulce María Moncho Rodríguez, Sergio Cabello , Cristina Auger Acosta, Alex Rovira Cañellas, Merce Bonastre Garcia, Ana Zabalza de Torres, Joaquin Castillo Justribo, Anna Laura Salerno
Funding agency: Instituto de Salud Carlos III
Funding: 96800
Reference: PI19/00950
Duration: 01/01/2020 - 31/12/2022

Papel de los factores hormonales relacionados con la mujer en el riesgo y pronóstico de la E.M.

IP: Mar Tintore Subirana
Collaborators: Susana Otero Romero, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Cristina Auger Acosta, Alex Rovira Cañellas, Joaquin Castillo Justribo, Milagros Fraga Pereira, Georgina Arrambide García
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI15/00170
Duration: 01/01/2016 - 31/12/2019

Related news

The program, promoted by Biocat in collaboration with CIMIT (Boston), is aimed at entrepreneurs in the process of bringing their technology to market in the next few years.

Related professionals

Elena Huerga Núñez

Elena Huerga Núñez

Administration and Management
Neuroradiology
Read more
Ana Maria Nieto Montoya

Ana Maria Nieto Montoya

Administration and Management
Neuroradiology
Read more
Sahyly Siurana Montilva

Sahyly Siurana Montilva

Neuroradiology
Read more
Silvana Isabel Sarria Estrada

Silvana Isabel Sarria Estrada

Neuroradiology
Read more

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.